Overview

Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer

Status:
Completed

Trial end date:
2002-05-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Radiolabeled monoclonal antibodies can locate tumor cells and deliver tumor-killing substances to them without harming normal cells. Chemotherapy uses different ways to stop tumor cells from dividing so they stop growing or die. Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by radioimmunotherapy or chemotherapy used to kill tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radioimmunotherapy with or without doxorubicin plus peripheral stem cell transplantation in treating patients who have thyroid cancer.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Garden State Cancer Center at the Center for Molecular Medicine and Immunology

Treatments:

Antibodies
Antibodies, Monoclonal
Antineoplastic Agents, Immunological
Doxorubicin
Immunoglobulins
Liposomal doxorubicin